Results 271 to 280 of about 12,784,255 (313)
Some of the next articles are maybe not open access.
Targets for therapy in ependymoma
Targeted Oncology, 2011Ependymomas are among the rarest type of glioma and display significant heterogeneity based on patient age and tumor location. Treatment strategies include surgery and radiation, but the use of chemotherapy remains more controversial. Chemotherapy has been widely utilized in the pediatric population due to more aggressive disease in this cohort, and ...
openaire +2 more sources
Autoimmunity Reviews, 2019
The intention of this paper is to review actual developments in target therapy in SLE. Target therapy includes both the objective of intervention and the aim of treatment. The objective should be linked to the pathophysiologic process of SLE; the aim has to be in any case an improved outcome. The current therapeutic in SLE is guided mostly by secondary
openaire +2 more sources
The intention of this paper is to review actual developments in target therapy in SLE. Target therapy includes both the objective of intervention and the aim of treatment. The objective should be linked to the pathophysiologic process of SLE; the aim has to be in any case an improved outcome. The current therapeutic in SLE is guided mostly by secondary
openaire +2 more sources
Targeting complement in therapy
Immunological Reviews, 2001Summary:With increasing evidence that complement activation significantly contributes to the pathogenesis of a large number of inflammatory diseases, strategies that interfere with its deleterious action have become a major focus in pharmacological research. Endogenous soluble complement inhibitors (C1 inhibitor, recombinant soluble complement receptor
openaire +2 more sources
Targeted Therapies for Melanoma
2015Since the discovery of activating mutations in the BRAF oncogene and also stimulation of immune mediated antitumor response in melanoma, there has been remarkable progress in the development of targeted therapies for unresectable and metastatic melanoma. This article addresses the latest developments of BRAF/MEK/ERK pathway signaling.
U, Leiter, F, Meier, C, Garbe
openaire +2 more sources
Diabetes Research and Clinical Practice, 1995
Non-insulin-dependent diabetes (NIDDM) is a common multimetabolic disorder with potential (and potentially severe) long-term complications affecting large and small blood vessels. Where microvascular complications (retinopathy, nephropathy and neuropathy) are concerned, the Diabetes Control and Complications Trial (DCCT), as well as much circumstantial
openaire +2 more sources
Non-insulin-dependent diabetes (NIDDM) is a common multimetabolic disorder with potential (and potentially severe) long-term complications affecting large and small blood vessels. Where microvascular complications (retinopathy, nephropathy and neuropathy) are concerned, the Diabetes Control and Complications Trial (DCCT), as well as much circumstantial
openaire +2 more sources
Rational combinations of targeted cancer therapies: background, advances and challenges
Nature reviews. Drug discovery, 2022Hao-Jie Jin, Liqin Wang, R. Bernards
semanticscholar +1 more source
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Nature Reviews Rheumatology, 2022B. Soós +5 more
semanticscholar +1 more source

